347 related articles for article (PubMed ID: 27123924)
1. Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes.
Mondelaers A; Sanchez-Cañete MP; Hendrickx S; Eberhardt E; Garcia-Hernandez R; Lachaud L; Cotton J; Sanders M; Cuypers B; Imamura H; Dujardin JC; Delputte P; Cos P; Caljon G; Gamarro F; Castanys S; Maes L
PLoS One; 2016; 11(4):e0154101. PubMed ID: 27123924
[TBL] [Abstract][Full Text] [Related]
2. Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection.
Van Bockstal L; Bulté D; Hendrickx S; Sadlova J; Volf P; Maes L; Caljon G
Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():16-21. PubMed ID: 32388220
[TBL] [Abstract][Full Text] [Related]
3. Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum.
Hendrickx S; Mondelaers A; Eberhardt E; Lachaud L; Delputte P; Cos P; Maes L
Parasitol Res; 2015 Jul; 114(7):2561-5. PubMed ID: 25877390
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model.
Hendrickx S; Mondelaers A; Eberhardt E; Delputte P; Cos P; Maes L
Antimicrob Agents Chemother; 2015 Aug; 59(8):4714-8. PubMed ID: 26014955
[TBL] [Abstract][Full Text] [Related]
5. High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms.
Fernandez-Prada C; Sharma M; Plourde M; Bresson E; Roy G; Leprohon P; Ouellette M
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):165-173. PubMed ID: 29602064
[TBL] [Abstract][Full Text] [Related]
6. Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis.
Van Bockstal L; Sádlová J; Suau HA; Hendrickx S; Meneses C; Kamhawi S; Volf P; Maes L; Caljon G
Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():1-7. PubMed ID: 31525614
[TBL] [Abstract][Full Text] [Related]
7. A Telomeric Cluster of Antimony Resistance Genes on Chromosome 34 of Leishmania infantum.
Tejera Nevado P; Bifeld E; Höhn K; Clos J
Antimicrob Agents Chemother; 2016 Sep; 60(9):5262-75. PubMed ID: 27324767
[TBL] [Abstract][Full Text] [Related]
8. Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum.
Hendrickx S; Boulet G; Mondelaers A; Dujardin JC; Rijal S; Lachaud L; Cos P; Delputte P; Maes L
Parasitol Res; 2014 May; 113(5):1875-81. PubMed ID: 24615359
[TBL] [Abstract][Full Text] [Related]
9. Miltefosine-resistant Leishmania infantum strains with an impaired MT/ROS3 transporter complex retain amphotericin B susceptibility.
Mondelaers A; Hendrickx S; Van Bockstal L; Maes L; Caljon G
J Antimicrob Chemother; 2018 Feb; 73(2):392-394. PubMed ID: 29165590
[TBL] [Abstract][Full Text] [Related]
10. Evidence of a drug-specific impact of experimentally selected paromomycin and miltefosine resistance on parasite fitness in Leishmania infantum.
Hendrickx S; Beyers J; Mondelaers A; Eberhardt E; Lachaud L; Delputte P; Cos P; Maes L
J Antimicrob Chemother; 2016 Jul; 71(7):1914-21. PubMed ID: 27084919
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
[TBL] [Abstract][Full Text] [Related]
12. Miltefosine enhances the fitness of a non-virulent drug-resistant Leishmania infantum strain.
Eberhardt E; Bulté D; Van Bockstal L; Van den Kerkhof M; Cos P; Delputte P; Hendrickx S; Maes L; Caljon G
J Antimicrob Chemother; 2019 Feb; 74(2):395-406. PubMed ID: 30412253
[TBL] [Abstract][Full Text] [Related]
13. Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance.
Pérez-Victoria FJ; Gamarro F; Ouellette M; Castanys S
J Biol Chem; 2003 Dec; 278(50):49965-71. PubMed ID: 14514670
[TBL] [Abstract][Full Text] [Related]
14. Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition.
Bulté D; Van Bockstal L; Dirkx L; Van den Kerkhof M; De Trez C; Timmermans JP; Hendrickx S; Maes L; Caljon G
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009622. PubMed ID: 34292975
[TBL] [Abstract][Full Text] [Related]
15. In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization.
Shaw CD; Lonchamp J; Downing T; Imamura H; Freeman TM; Cotton JA; Sanders M; Blackburn G; Dujardin JC; Rijal S; Khanal B; Illingworth CJ; Coombs GH; Carter KC
Mol Microbiol; 2016 Mar; 99(6):1134-48. PubMed ID: 26713880
[TBL] [Abstract][Full Text] [Related]
16. Miltefosine Resistant Field Isolate From Indian Kala-Azar Patient Shows Similar Phenotype in Experimental Infection.
Khanra S; Sarraf NR; Das AK; Roy S; Manna M
Sci Rep; 2017 Sep; 7(1):10330. PubMed ID: 28871097
[TBL] [Abstract][Full Text] [Related]
17. Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis.
Bhandari V; Kulshrestha A; Deep DK; Stark O; Prajapati VK; Ramesh V; Sundar S; Schonian G; Dujardin JC; Salotra P
PLoS Negl Trop Dis; 2012; 6(5):e1657. PubMed ID: 22629478
[TBL] [Abstract][Full Text] [Related]
18. Leishmania infantum amastigotes resistant to nitric oxide cytotoxicity: Impact on in vitro parasite developmental cycle and metabolic enzyme activities.
Holzmuller P; Hide M; Sereno D; Lemesre JL
Infect Genet Evol; 2006 May; 6(3):187-97. PubMed ID: 15905133
[TBL] [Abstract][Full Text] [Related]
19. Deep-sequencing revealing mutation dynamics in the miltefosine transporter gene in Leishmania infantum selected for miltefosine resistance.
Laffitte MC; Leprohon P; Légaré D; Ouellette M
Parasitol Res; 2016 Oct; 115(10):3699-703. PubMed ID: 27457482
[TBL] [Abstract][Full Text] [Related]
20. Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs.
Rastrojo A; García-Hernández R; Vargas P; Camacho E; Corvo L; Imamura H; Dujardin JC; Castanys S; Aguado B; Gamarro F; Requena JM
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):246-264. PubMed ID: 29689531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
